Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI

Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Recursion, about how the company uses AI and machine learning to accelerate drug discovery and development at scale. Tune in to hear Gibson discuss how AI is transforming the biopharmaceutical industry by increasing efficiency and lowering discovery costs.

The AI Podcast · Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI – Ep. 230|

Time Stamps

0:58: Background on Recursion
6:23: Recursion’s approach to drug discovery
12:06: Empirical data generation and generative AI prediction
17:46: How supercomputing is accelerating drug discovery
22:32: What is techbio?
29:15: The future — using natural language prompts to work with AI systems\
31:44: Recursion’s plans for future

You Might Also Like:|

Cardiac Clarity: Dr. Keith Channon Talks Revolutionizing Heart Health With AI – Ep. 212

Caristo Diagnostics has developed an AI-powered solution for detecting coronary inflammation in cardiac CT scans. Dr. Keith Channon, cofounder and chief medical officer of the company, discusses how Caristo uses AI to improve treatment plans and risk predictions by providing patient-specific readouts.

Cofounder of Annalise.ai Aengus Tran on Using AI as a Spell Check for Health Checks – Ep. 207

Clinician-led healthcare AI company Harrison.ai has built annalise.ai. This AI solution serves as a “spell checker” for radiologists — flagging critical findings to improve the speed and accuracy of radiology image analysis, reducing misdiagnoses. Harrison.ai CEO and cofounder Aengus Tran discusses the potential of autonomous AI systems to scale global healthcare capacity.

Matice Founder Jessica Whited on Harnessing Regenerative Species for Medical Breakthroughs – Ep. 198

Matice Biosciences is using AI to study the regeneration of tissues in animal species known as super-regenerators, such as salamanders and planarians. Jessica Whited, a regenerative biologist at Harvard and cofounder of Matice Biosciences, discusses the company’s goal to harness regenerative species and AI to develop new treatments that help humans heal from injuries without scarring.

Bojan Tunguz, Johnny Israeli on How AI and Crowdsourcing Can Advance Vaccine Distribution – Ep. 195

Artificial intelligence is teaming up with crowdsourcing to improve the thermo-stability of mRNA vaccines, making distribution more accessible worldwide. Bojan Tunguz, a physicist and senior system software engineer at NVIDIA, and Johnny Israeli, senior manager of AI and cloud software at NVIDIA, discuss the fusion of AI, crowdsourcing and machine learning and its potential in drug discovery.